For clinical researchers involved with COVID-19, understanding its impact on cardiovascular homeostasis and the underlying pathophysiology is essential. In this article, Dr. Lazar Mandinov, Sr. Medical Director at Parexel, outlines the most significant current evidence and uncertainties, and provides practical guidance for conducting clinical trials related to COVID-19.
Most Recent Flipbooks
In this article, experts from the Parexel Pediatric Collaborative Group review current findings and consider how sponsors can adapt their studies to changing conditions during COVID19.
This lay summary discusses what the guidance means for anyone in the USA who may be involved in or associated with a clinical trial.
Updated every day, in a single source
If regulatory and payer landscapes are so different, then why bring the two worlds together?
Parexel offers a complimentary, educational workshop custom built to your evidence and market access needs.